Predict your next investment

Emboline company logo
HEALTHCARE | Medical Devices & Equipment / Surgical Devices
emboline.com

See what CB Insights has to offer

Total Raised

$81.56M

Investors Count

5

Deal Terms

1

Emboline Funding, Emboline Valuation & Emboline Revenue

8 Fundings

Emboline's latest funding round was a Series D for $55M on May 25, 2021.

Emboline's valuation in April 2018 was $14.05M.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

5/25/2021

Series D

$55M

3

2/11/2021

Series C - II

$99M

10

9/15/2020

Series C

$99M

10

1/30/2020

Bridge

$99M

10

4/19/2018

Series B

$99M

$14.05M

10

Date

5/25/2021

2/11/2021

9/15/2020

1/30/2020

4/19/2018

Round

Series D

Series C - II

Series C

Bridge

Series B

Amount

$55M

$99M

$99M

$99M

$99M

Investors

Valuation

$14.05M

Revenue

Sources

3

10

10

10

10

Emboline Deal Terms

1 Deal Term

Emboline's deal structure is available for 1 funding round, including their Series B from April 19, 2018.

Round

Series B

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

Emboline Investors

5 Investors

Emboline has 5 investors. SV Tech Ventures invested in Emboline's Series D funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

4/19/2018

5/25/2021

4
Series B, Series C (2020), Series C - II (2021), Series D (2021)

Venture Capital

California

00/00/0000

00/00/0000

Shangbay Capital

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

Matrix Capital Management

Subscribe to see more

Hedge Fund

Massachusetts

00/00/0000

00/00/0000

GAM

Subscribe to see more

Asset/Investment Management

Switzerland

00/00/0000

00/00/0000

CardioLogical Solutions

Subscribe to see more

Corporation

California

First funding

4/19/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

5/25/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Shangbay Capital

Matrix Capital Management

GAM

CardioLogical Solutions

Rounds

4
Series B, Series C (2020), Series C - II (2021), Series D (2021)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Venture Capital

Hedge Fund

Asset/Investment Management

Corporation

Location

California

California

Massachusetts

Switzerland

California

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.